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Background: Increased resting heart rate (HR) due to sympathetic hyperactivity is associated
with coronary risk factors and increased cardiovascular events. Acute myocardial infarction
(AMI) is accompanied by autonomic imbalance, which is characterized by sympathetic activation
and parasympathetic inactivation. Although an increased HR in patients with acute coronary
syndrome has been reported to be associated with 30-day and 6-month mortality before the
coronary intervention era, it is unclear if an increased HR on admission is associated with the
prognosis of AMI in the coronary intervention era.
Methods: We enrolled 200 consecutive patients with AMI within 24 h of symptom onset. All
patients underwent coronary angiography. They were divided into quartiles based on resting HR
on admission.
Results: There was no difference in coronary risk factors and previous medical treatment among
the four groups. Anterior AMI was signiﬁcantly lower in the lowest quartile compared with other
quartiles. There was no difference in peak creatine kinase value among the four groups, however
left ventricular ejection fraction (LVEF) before discharge evaluated by echocardiography in the
highest quartile group was signiﬁcantly reduced compared to other quartiles. An increased HR
was signiﬁcantly associated with in-hospital death. Patients in the highest quartile of HR were
about nine times more likely to have a poor prognosis after AMI compared to those in the
lowest quartile. Multiple logistic analysis revealed that HR ≥93 was an independent risk factor
for in-hospital death. HR was signiﬁcantly associated with Killip class and LVEF on admission.
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cute myocardial infarction (AMI) is a leading cause of death
mong adults and AMI survivors have an increased risk of
eveloping heart failure. It is important to evaluate patient
isk such as cardiac remodeling and future adverse events in
he early stage after AMI.
AMI is accompanied by imbalanced autonomic ner-
ous activity, which is characterized by activation of
he sympathetic nervous system and inactivation of the
arasympathetic nervous system [1—5]. Postinfarct sympa-
hetic hyperactivity leads to high levels of extracellular
orepinephrine in the heart after AMI, which increases
he risk of cardiac arrhythmias and mortality [6—9]. It is
ell known that resting heart rate (HR) reﬂects autonomic
ctivity, and several studies have also shown that rest-
ng HR is correlated with hyperglycemia, hyperinsulinemia,
etabolic syndrome, and mortality [10—14].
An elevated plasma glucose (PG) and white blood cell
WBC) count have been associated with a poor outcome of
MI both before and after the coronary intervention era
15—19]. Although an increased HR in the patients with acute
oronary syndrome has been reported to be associated with
0-day and 6-month mortality before the coronary interven-
ion era, it is unclear if an increased HR on admission is
ssociated with the prognosis of AMI in the coronary inter-
ention era [20,21].
Therefore, we examined the association between HR on
dmission and cardiac outcome after AMI.
ethods
tudy population
e retrospectively studied 200 consecutive patients who
ere admitted to the Department of Cardiology at
umamoto Medical Center within 24 h after the onset of
MI and underwent coronary angiography between January
008 and September 2009 (Table 1). The diagnosis of AMI was
ade by Universal Deﬁnition of Myocardial Infarction [22].
he subjects were divided into quartiles based on resting
R.
Blood pressure, HR, PG, WBC count, glomerular ﬁltra-
ion rate (GFR), and hemoglobin (Hb) were measured at the
ime of arrival at the emergent unit of Kumamoto Medical
enter. GFR was calculated using the abbreviated Modiﬁca-
ion of Diet in Renal Disease Study formula [23]. Creatine
inase (CK) was measured every 4—6h after admission, and
eak CK was obtained in 199 patients. One patient was dead
efore peak CK was obtained. Blood samples for measures
f PG and WBC count were obtained at the time of hospital
dmission. Total cholesterol (T-Cho), high-density lipopro-
ein cholesterol (HDL-C), low-density lipoprotein cholesterol
LDL-C), triglyceride (TG), PG, and hemoglobin A1c (HbA1c)






pate that increased HR on admission predicts for poor cardiac
er AMI.
ology. Published by Elsevier Ireland Ltd. All rights reserved.
nalysis of coronary risk factors for coronary
rtery disease
he traditional risk factors for coronary artery disease used
or statistical analysis were hypertension (HT), lipid proﬁles
T-Cho, HDL-C, LDL-C, and TG), current cigarette smok-
ng habit, body mass index (BMI), and diabetes mellitus
DM).
HT was deﬁned as blood pressure≥ 140/90mmHg and/or
he use of antihypertensive medication. Current cigarette
moking was deﬁned as ≥10 cigarettes/day for 10 years
ncluding cessation of smoking within 1 year. DM was deﬁned
s a fasting blood glucose≥ 126mg/dl and/or HbA1c≥ 6.5%
r the use of antidiabetic medication.
oronary angiography and coronary intervention
mergent coronary angiography was performed in all
atients in the acute phase of AMI. The use of coro-
ary angiography and reperfusion therapy was based on
he discretion of the physician. One hundred and eighty-
ve patients underwent coronary intervention, ﬁve patients
nderwent coronary artery bypass surgery. Four patients
ere treated with medical treatment due to coronary spas-
ic angina. Six patients were also treated with medical
reatment because it was difﬁcult to perform coronary inter-
ention (culprit lesions were located at the peripheral site
f coronary arteries).
AMI sites were divided into 2 groups (anterior AMI and
on-anterior AMI). Diseased vessel was deﬁned as coro-
ary arteries narrowed ≥75% and the patients were divided
nto 2 groups (single-vessel disease and multi-vessel dis-
ase).
valuation of left ventricular ejection fraction by
chocardiography
ll patients underwent echocardiography by laboratory
echnicians after admission and before discharge. Left ven-
ricular ejection fraction (LVEF) was measured by modiﬁed
impson method. Poor cardiac function was deﬁned as LVEF
efore discharge < 50%.
n-hospital death
n-hospital death was deﬁned as all-cause death during hos-
italization.esults were expressed as the mean± SD when variables
ere continuous and normally distributed, and the median
interquartile range) when variables were continuous but
ot normally distributed. Continuous variables were com-
ared between groups using a two-tailed unpaired t-test
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Table 1 Clinical and angiographic characteristics of acute myocardial infarction by quartiles of heart rate (HR).
Quartile 1 Quartile 2 Quartile 3 Quartile 4
HR < 64 (n = 50) HR: 64—79 (n = 49) HR: 80—92 (n = 51) HR≥ 93 (n = 50)
Age (years) 67± 13 71± 13 70± 13 69± 16
Gender (male/female) 37/13 34/15 33/18 40/10
Hypertension 32 36 41 38
Diabetes mellitus 11 20 16 21
BMI (%) 22.8± 3.2 23.1± 2.5 22.8± 3.1 23.4± 3.1
Current smoker (%) 13 14 18 20
T-Cho (mg/dl) 187± 36 184± 40 187± 36 186± 44
HDL-C (mg/dl) 42± 10 45± 11 46± 13 44± 13
LDL-C (mg/dl) 118± 32 114± 34 118± 29 118± 34
TG (mg/dl) 98 (76—148) 111 (79—154) 107 (77—145) 98 (66—145)
Previous medical treatment
Hypertension 25 31 34 26
Diabetes mellitus 9 12 15 18
Dyslipidemia 8 10 14 6
Active medical treatment
Aspirin 48 46 51 50
Clopidogrel or ticlopidine or cilostazol 46 44 45 45
ACE-I/ARB 31/9 22/14 30/14 39/7
Beta-blocker 11 13 21* 22*
CaCB 12 12 12 13
Nitrate 12 15 10 12
Statin 28 30 31 27















LTG, triglyceride; ACE-I, angiotensin-converting enzyme inhibitor;
* p < 0.05 vs quartile 1.
or Mann—Whitney U-test, as appropriate. Categorical vari-
ables were compared by Chi-square analysis with Fisher’s
exact probability. Odds ratios (OR) and 95% conﬁdence
intervals (CI) of in-hospital death were calculated using
logistic regression analysis. To assess the determinants of
the increased HR on admission, multiple regression analysis
was performed after a stepwise regression analysis including
all clinical variables in Tables 1 and 2. Statistical signiﬁcance
was deﬁned as p < 0.05.
Results
Clinical and angiographic characteristics
The HR ranged from 29 to 200 beats per minute (bpm).
The median HR was 80 bpm and the interquartile range was
64—93 bpm. Tables 1 and 2 show the clinical and angio-
graphic characteristics of the patients by quartiles of HR.
The coronary risk factors and previous medical treatment
on admission were not signiﬁcantly different among the four
groups (Table 1). Anterior AMI was more frequent in quartiles
2, 3, and 4 than in quartile 1. However ST-elevation myocar-
dial infarction (STEMI), previous MI, pre infarction angina,
and coronary intervention were not signiﬁcantly different
among the four groups. PG and WBC count in quartile 4 were
signiﬁcantly increased compared with quartile 1. Although
LVEF on admission in quartile 4 was signiﬁcantly reduced





(angiotensin receptor blocker; CaCB, calcium channel blocker.
ile 4 was signiﬁcantly reduced compared to other groups
Table 2).
elationship between HR and in-hospital death
n the present study, 14 in-hospital deaths were observed. A
igher HR was observed in patients with in-hospital death.
atients in quartile 4 were about nine times more likely to
ave in-hospital death than those in quartile 1 (Table 3).
ogistic analysis for the risk of poor cardiac
unction
ultiple logistic analysis using GFR and HR≥ 93 on admis-
ion, STEMI, anterior AMI, and peak CK showed that peak
K, GFR, and HR≥ 93 were the predictive independent risk
actors for poor cardiac function (Table 4).
ogistic analysis for the risk of in-hospital deathultiple logistic analysis using age, GFR, Hb, Killip class,
VEF, and HR≥ 93 on admission, anterior AMI, and peak CK
howed that HR≥ 93 (OR, 8.5; p = 0.018, CI, 1.4—49) was the
ost predictive independent risk factor for in-hospital death
Table 5).
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Table 2 Angiographic characteristics of acute myocardial infarction by quartiles of heart rate (HR).
Quartile 1 Quartile 2 Quartile 3 Quartile 4
HR < 64 (n = 50) HR: 64—79 (n = 49) HR: 80—92 (n = 51) HR≥ 93 (n = 50)
Time (h) from symptom
onset to admission
1.8 (1.0—4.5) 2.0 (1.0—5.1) 3.0 (1.1—7.4) 2.8 (1.0—6.0)
Time (h) from symptom
onset to PCI
3.5 (2.4—6.0) 3.8 (2.7—9.1) 5.3 (2.9—8.9) 4.4 (3.0—8.2)
SBP (mmHg) on
admission
128± 37 137± 28 138± 27 134± 34
Killip class (I/II/III/IV) 46/0/0/4 39/7/2/1 41/4/2/4 30/9/6/5
STEMI 39 30 33 39
Anterior AMI 16 34* 32* 29*
Previous MI 6 3 4 2
Preinfarction angina 18 27 20 15
Coronary multi-vessel
involvement
19 29 24 25
Coronary intervention 47 45 47 46
PG (mg/dl) on admission 149 (115—215) 153 (124—211) 166 (128—208) 167 (138—230)*
WBC count (/mm3) on
admission
8950 (7400—11,200) 8100 (6075—10,875) 10,000 (7450—12,000)† 11,300 (7300—14,500)*,†
GFR (ml/min/1.73m2)
on admission
70.5± 26.1 71.9± 30.0 71.5± 28.9 64.8± 24.0
Hb (g/dl) on admission 13.5± 1.7 13.2± 2.1 13.2± 2.2 13.5± 2.2
Peak CK (IU/l) 1376 (614—2687) 1599 (540—3873) 1610 (482—2849) 2345 (949—4383)
LVEF (%) on admission 59.1± 9.3 54.3± 12.6* 56.3± 11.1 51.4± 11.5*,§
LVEF (%) before
discharge
60.2± 9.8 57.1± 10.3 57.8± 10.0 52.1± 10.7*,†,§
PCI, percutaneous coronary intervention; SBP, systolic blood pressure; STEMI, ST-elevation myocardial infarction; AMI, acute myocardial
infarction; PG, plasma glucose; WBC, white blood cell; GFR, glomerular ﬁltration rate; Hb, hemoglobin; CK, creatine phosphokinase;
LVEF, left ventricular ejection fraction.
* p < 0.05 vs quartile 1.
† p < 0.05 vs quartile 2.
§ p < 0.05 vs quartile 3.
Table 3 Poor cardiac function and in-hospital death by quartiles of heart rate (HR).
Poor cardiac function In-hospital death
n (%) OR 95% CI p n (%) OR 95% CI p
Quartile 1 (HR < 64) (n = 50) 7 (14) 1.0 — — 1 (2.0) 1.0 — —
Quartile 2 (HR: 64—79) (n = 49) 9 (18) 1.4 0.47—4.1 0.56 3 (6.1) 3.2 0.32—32 0.32


















(Quartile 4 (HR≥ 93) (n = 50) 20 (40) 4.1 1
OR, odds ratio; CI, conﬁdence interval.
linical determinants of HR
o assess the determinants of high HR at the time of
dmission to the hospital, multiple regression analysis was
erformed after stepwise regression analysis that included
he clinical variables in Table 1. The results revealed that
high HR was signiﬁcantly associated with Killip class and
VEF on admission (r = 7.0, p < 0.0002) (Table 6).iscussion
e report for the ﬁrst time that increased HR on admis-




d1 0.0048 8 (16) 9.3 1.1—78 0.039
nd in-hospital death in patients with AMI. In addition, HR
as signiﬁcantly associated with Killip class and LVEF on
dmission.
During hospitalization, 14 patients (7%) died (10 of car-
iac death, 2 from multiple organ failure, 1 from a bleeding
omplication after bypass surgery, 1 from pneumonia).
he main cause of death in quartile 4 was cardiac death
63%).
Multiple logistic analysis showed that HR≥ 93 on admis-
ion and anterior AMI were risk factors for in-hospital
eath. It has been reported that patients with an inferior
r posterior AMI are more likely to develop bradycardia
ue to conduction system abnormalities when compared to
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Table 4 Logistic analysis for the risk of poor left ventricular function.
Univariate model Multivariate model
OR (95% CI) p OR (95% CI) p
Age 1.0 (1.0—1.0) 0.079 — —
STEMI 2.6 (1.1—6.0) 0.023 1.9 (0.76—4.8) 0.17
Preinfarction angina 1.6 (0.85—3.1) 0.14 — —
Coronary intervention 1.3 (0.36—4.9) 0.67 — —
PG on admission 1.0 (1.0—1.0) 0.35 — —
WBC count on admission 1.0 (1.0—1.0) 0.61 — —
GFR on admission 0.99 (0.98—1.0) 0.036 0.99 (0.97—1.0) 0.024
Hb on admission 0.91 (0.78—1.1) 0.24 — —
Peak CK 1.0 (1.0—1.0) 0.0009 1.0 (1.0—1.0) 0.019
Anterior MI 2.2 (1.1—4.3) 0.026 2.0 (0.96—4.3) 0.063
Killip class 1.3 (0.92—1.8) 0.14 — —
HR≥ 93 on admission 2.7 (1.3—5.3) 0.0055 2.2 (1.1—4.7) 0.033
OR, odds ratio; CI, conﬁdence interval; STEMI, ST-elevation myocardial infarction; PG, plasma glucose; WBC, white blood cell; GFR,
glomerular ﬁltration rate; Hb, hemoglobin; CK, creatine phosphokinase; MI, myocardial infarction; HR, heart rate.
Table 5 Logistic analysis for the risk of in-hospital death.
Univariate model Multivariate model
OR (95% CI) p OR (95% CI) p
Age 1.1 (1.0—1.2) 0.0015 1.0 (0.95—1.1) 0.46
STEMI 1.1 (0.32—3.5) 0.94 — —
Preinfarction angina 0.82 (0.27—2.6) 0.73 — —
Coronary intervention 0.45 (0.091—2.2) 0.33 — —
PG on admission 1.0 (1.0—1.0) 0.18 — —
WBC count on admission 1.0 (1.0—1.0) 0.86 — —
GFR on admission 0.95 (0.93—0.97) <0.0001 0.98 (0.94—1.0) 0.38
Hb on admission 0.57 (0.43—0.76) <0.0001 0.66 (0.42—1.0) 0.07
LVEF on admission 0.94 (0.89—0.98) 0.0083 0.98 (0.92—1.0) 0.50
Peak CK 1.0 (1.0—1.0) 0.0071 1.0 (1.0—1.0) 0.19
Anterior MI 5.3 (1.2—24) 0.033 7.4 (1.1—51) 0.042
Killip class 2.7 (1.7—4.3) <0.0001 1.5 (0.79—2.9) 0.21
HR≥ 93 on admission 4.4 (1.5—13) 0.0087 8.5 (1.4—49) 0.018
cardi
ectio
nOR, odds ratio; CI, conﬁdence interval; STEMI, ST-elevation myo
glomerular ﬁltration rate; Hb, hemoglobin; LVEF, left ventricular ej
HR, heart rate.
patients with an anterior or lateral AMI [24]. It was compat-
ible with the data that culprit RCA location in quartile 1 was
signiﬁcantly more frequent than those in other quartiles. On
the other hand, anterior or lateral AMI is a signiﬁcant predic-
tor of in-hospital death [24]. It was also compatible with the





Table 6 Determinants of a high heart rate based on multiple reg
Independent variables Regression coefﬁcients
Killip class 7.0
LVEF on admission −0.31
SBP 0.13
WBC count 0.001
p-Values are from multiple regression analysis after stepwise regressio
CI, conﬁdence interval; LVEF, left ventricular ejection fraction; SBP, syal infarction; PG, plasma glucose; WBC, white blood cell; GFR,
n fraction; CK, creatine phosphokinase; MI, myocardial infarction;
iﬁcantly more frequent than that in quartile 1. These data
uggested location of AMI might affect in-hospital adverse
vents.
STEMI has been reported to exacerbate long-term
ortality after AMI [25]. However it did not aggravate
oor cardiac function and in-hospital mortality in the
ression analysis.
Standard error 95% CI p
1.8 3.3—11 0.0002
0.14 −0.58 to −0.027 0.032
0.051 0.027—0.23 0.013
0.00038 0.0004—0.002 0.0028
n including all variables in Table 1.









































































resent study because it was a short-term observational
tudy.
On the other hand, preinfarction angina has been
hown to be associated with better clinical outcomes and
ardiac function after AMI [26]. However beneﬁcial effects
f preinfarction angina were not observed in this study.
eneﬁcial effects of early recanalization by PCI may have
asked those of preinfarction angina.
The present study indicated that HR on admission was
ssociated with Killip class, LVEF, systolic blood pressure,
nd WBC count on admission. When left ventricular func-
ion is depressed, systolic blood pressure is also reduced.
n addition, several compensatory mechanisms are acti-
ated, including sympathetic stimulation to increase HR and
ontractility and renal ﬂuid retention to increase preload.
ncreased HR and contractility increase myocardial oxy-
en demand and exacerbate ischemia. Fluid retention and
mpaired diastolic ﬁlling caused by tachycardia and ischemia
ay result in pulmonary congestion and hypoxia [27].
ecause Killip class is an index of heart failure and car-
iogenic shock after AMI, Killip class and LVEF on admission
ight affect HR on admission. On the other hand, systolic
lood pressure and WBC count on admission affected HR on
dmission. The data might indicate that sympathetic hyper-
ctivity followed by AMI increase both HR and systolic blood
ressure [1—5].
It is possible that HR was signiﬁcantly associated with
BC count on admission as a result of sympathetic hyper-
ctivity after AMI. Previous reports suggested sympathetic
yperactivity after AMI arose because of impairment of
eﬂexes from cardiac receptors, and the protracted state
ight explain delayed cardiovascular morbidity [1—9].
n the other hand, imbalanced autonomic nerve sys-
em after AMI accelerates inﬂammatory response because
ympathetic hyperactivity could increase production of
roinﬂammatory cytokines and impaired parasympathetic
ctivity could not suppress proinﬂammatory cytokines
hrough the direct effect to inﬂammatory cells [28—30]. Sev-
ral studies showed that macrophages and neutrophils have
crucial role in myocardial ischemia-reperfusion injury;
n excessive inﬂammatory response aggravates infarct size
31,32]. A high WBC count has been associated with large
nfarct size, impaired left ventricular function, and mortal-
ty after AMI [15].
Multiple logistic analysis showed that GFR and HR≥ 93
n admission and peak CK were risk factors for poor cardiac
unction after AMI. LVEF on admission in the highest HR quar-
ile was signiﬁcantly reduced compared to that in the lowest
R quartile. On the other hand, LVEF before discharge in the
ighest HR quartile was signiﬁcantly reduced compared to
hose in others although there was no difference in the peak
K value among 4 groups. Increased HR and contractility
ight increase myocardial oxygen demand and exacerbate
schemia [27], and might subsequently aggravate cardiac
emodeling after AMI. In addition, chronic kidney disease
as been shown to be associated with poor clinical outcomes
25,33]. Factors such as anemia, oxidative stress, altered
ytokine, derangements in calcium-phosphate homeostasis,
nd conditions conducive to coagulation might be most likely
nvolved [33]. Our data suggest that not only peak CK value
ut also GFR and increased HR might affect poor cardiac
unction after AMI.
[T. Honda et al.
Various factors might increase resting HR on admission in
atients with AMI. WBC and LVEF because imbalanced auto-
omic nerve system might cause tachycardia, which could
ggravate inﬂammatory response and myocardial ischemia
n patients with AMI.
Numerous studies have demonstrated that an elevated
G and WBC count and a decreased GFR and Hb on admission
re associated with impaired left ventricular function and
ncreased risk of mortality as the marker of inﬂammatory
esponse after AMI [15—21,33—35]. The present study indi-
ated that HR on admission is also a useful marker to stratify
atient risk after AMI to predict poor cardiac function and
n-hospital death.
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